HealthRX review
Both molecules are stated flat at every dose, which on a medication designed to be escalated is the disclosure worth more than the headline.
The verdict
HealthRX charges $165 a month for compounded semaglutide month to month and $214 for tirzepatide. Committing three months brings those to $133 and $209, and twelve months to $99 and $179. Every figure is stated to hold at any dose, so the number a buyer starts at is the number they are still paying at the top of the ladder.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 sellers by price
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Dose pricing
- Flat across doses
- From
- From $165/mo
- Dose published
- Yes
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Availability
- All 50 states claimed; no list published
HealthRX sells both molecules by injection alongside a wide catalog of other peptide and men's-health products, and the GLP-1 lines are priced independently of the rest of it. The figure the pages lead with belongs to a three-month term rather than to a month.
Who writes the prescription, and what do they see?
A prescription is issued before anything ships, and the pages set out the plans and the products rather than the clinician who writes them. Nothing names the prescriber or describes what the intake asks.
A prescription is written before anything ships, and the plan length is chosen at purchase rather than renewed month to month. What deserves weight in a comparison is not that structure, which is common, but the flat-dose statement attached to it. Almost every seller in this category prices by milligram or declines to say, so a buyer escalating from 0.25 mg to 2.4 mg over sixteen weeks usually has no way to know what the later months cost.
What happens when the dose goes up?
This is the part HealthRX does better than most of the market. Both molecules are stated flat at every dose, so the first sixteen weeks of escalation carry no price consequence at all, and the rate agreed at 0.25 mg is still the rate at the top of the ladder. Almost every seller in this comparison either prices by milligram or says nothing.
What the price includes
Six months bought month to month is $990 on semaglutide and $1,284 on tirzepatide. On the three-month plan the same span is $798 and $1,254, and at the annual rate it would be $594 and $1,074, though that rung requires the whole year paid as one term. The distance between paying monthly and committing a year is $66 a month on semaglutide and $35 on tirzepatide — a real discount on the first line and a thin one on the second.
What it claims, and what it cites
Both lines are compounded rather than manufactured, prepared by a pharmacy to order, and the FDA does not review a compounded preparation before it is dispensed. No pharmacy is named on either line.
Where it holds up, and where it does not
- Strength: Both molecules stated flat at every dose
- Strength: Term rates published beside each other
- Strength: The dose disclosure is the rarest one in this category
- Limitation: The lowest rungs need a full year
- Limitation: The advertised $133 is a prepay rate, not the standing one
- Limitation: Nothing published about stopping partway
- Limitation: No pharmacy named and no state list recorded
What the evidence says about this kind of treatment
The assessment above is about HealthRX. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A buyer who expects to escalate and wants the later months priced.
- Wrong for
- A buyer who wants to pay month to month.
The evidence behind what HealthRX prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How HealthRX compares
| Seller | Who it suits | Go |
|---|---|---|
| Readers who want the dose question answered in writing before anything else | See Somi Health → | |
| EverSlim | A reader who wants one monthly charge covering the medication, the visit and the postage, without a prepay term attached to reach the rate. | See EverSlim → |
| Readers who want the pharmacy and the medical group named before starting | See Trellis Vitality → |
More GLP-1 sellers by price reviews: EdenEmbodyEnhance MDFoundGalaHumeCare+
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Does the price change as my dose goes up?
- No. Both molecules are stated flat at every dose, so the rate at 2.4 mg is the rate at 0.25 mg.
- What does the lowest published rate require?
- Twelve months. Semaglutide is $99 a month on that term, $133 on the three-month plan and $165 month to month; tirzepatide is $179, $209 and $214.
- Is the annual plan worth committing to?
- On semaglutide it saves $66 a month against the month-to-month rate, which is substantial. On tirzepatide it saves $35, so the flexibility may be worth more than the discount there.
- Is HealthRX expensive compared with other GLP-1 sellers by price?
- HealthRX publishes a starting figure of $165/mo. Across the 402 GLP-1 sellers by price we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts HealthRX below the median, toward the cheaper end. The other 178 GLP-1 sellers by price we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.